在最新的研究中，南京大学医学院 江春平/吴俊华团队 ...

经过DataTwin图像查重流程，发现李春晓、江萍、王俊杰团队等人近期在某权威期刊上发表的"Sorafenib enhanced the function of myeloid-derived suppressor cells in ...

Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is ...

为解决肝细胞癌（HCC）患者等待肝移植期间肿瘤进展问题，相关研究人员开展 Histotripsy 作为桥接治疗的研究，发现其可使肿瘤完全坏死，为 HCC 治疗提供新选择。

Discover why, to improve screening efficiency, it is crucial to identify patients with elevated hepatocellular carcinoma risk ...

慢性乙型肝炎（Chronic hepatitis B,CHB）是全球公共卫生的重大挑战之一，影响约3亿人。HBsAg血清清除被认为是CHB的功能性治愈终点，可降低发生肝细胞癌（hepatocellular ...

Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma? The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny ...

One of the world's most globally recognised liver cancer treatments will receive public funding from today. Tecentriq (atezolizumab) in combination with bevacizumab will help the 70 or so New ...

New data show that external-beam radiation therapy yielded superior local control and progression-free survival vs TACE in ...